Sionna Therapeutics, Inc. (SION)
5.59
+0.30
(+5.67%)
USD |
NASDAQ |
Aug 24, 16:00
5.55
-0.04
(-0.72%)
After-Hours: 20:00
Sionna Therapeutics EPS Diluted (Quarterly) : -0.6619 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6619 |
| March 31, 2026 | -0.5941 |
| December 31, 2025 | -0.457 |
| September 30, 2025 | -0.4561 |
| June 30, 2025 | -0.4094 |
| March 31, 2025 | -0.3738 |
| Date | Value |
|---|---|
| December 31, 2024 | -0.3592 |
| September 30, 2024 | -0.5766 |
| June 30, 2024 | -0.1938 |
| March 31, 2024 | -0.2685 |
| December 31, 2023 | -0.2692 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vertex Pharmaceuticals, Inc. | 4.310 |
| ACADIA Pharmaceuticals, Inc. | 0.1822 |
| Immunic, Inc. | -0.8021 |
| Alnylam Pharmaceuticals, Inc. | 1.207 |
| Anika Therapeutics, Inc. | 0.2412 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -29.89M |
| Total Expenses (Quarterly) | 29.89M |
| Enterprise Value | 35.96M |
| Earnings Yield | -38.80% |
| Normalized Earnings Yield | -38.80 |